References
Aksentijevich I, Zhou Q. NF-κB pathway in autoinflammatory diseases: dysregulation of protein modifications by ubiquitin defines a new category of autoinflammatory diseases. Front Immunol. 2017;8:399.
Beck DB, et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med. 2020;383(27):2628–38.
Bourbon E, Heiblig M, Gerfaud-Valentin M, Barba T, Durel CA, Lega JC, et al. Therapeutic options in Vexas syndrome: insights from a retrospective series. Blood. 2021. https://doi.org/10.1182/blood.2020010177.
Charbonneau ME, Passalacqua KD, Hagen SE, et al. Perturbation of ubiquitin homeostasis promotes macrophage oxidative defenses. Sci Rep. 2019; 9(1):10245. https://doi.org/10.1038/s41598-019-46526-9.
Egues Dubuc CA, et al. THU0452 secondary hemophagocytic lymphohistiocytosis: a series of 11 patients. Literature review. Ann Rheum Dis. 2013;72(Suppl 3):A317–A317.
Gurnari C, Pagliuca S, Durkin L, Terkawi L, Awada H, Kongkiatkamon S, et al. Vacuolization of hematopoietic precursors: an enigma with multiple etiologies. Blood. 2021. https://doi.org/10.1182/blood.2021010811.
Henter J-I, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31.
Lee SMS, Fan BE, Lim JH, Goh LL, Lee JSS, Koh LW. A case of VEXAS syndrome manifesting as Kikuchi-Fujimoto disease, relapsing polychondritis, venous thromboembolism and macrocytic anaemia. Rheumatology (Oxford). 2021. https://doi.org/10.1093/rheumatology/keab200.
Magnol M, Couvaras L, Degboé Y, Delabesse E, Bulai-Livideanu C, Ruyssen-Witrand A, et al. VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapy. Rheumatology. 2021. https://doi.org/10.1093/rheumatology/keab211.
Oganesyan A, Jachiet V, Chasset F, Hirsch P, Hage-Sleiman M, Fabiani B, et al. VEXAS syndrome: still expanding the clinical phenotype. Rheumatology. 2021. https://doi.org/10.1093/rheumatology/keab225.
Poulter JA, Collins JC, Cargo C, de Tute RM, Evans P, Ospina Cardona D, et al. Novel somatic mutations in UBA1 as a cause of VEXAS syndrome. Blood. 2021.https://doi.org/10.1182/blood.2020010286.
Rouphael NG, et al. Infections associated with haemophagocytic syndrome. Lancet Infect Dis. 2007;7(12):814–22.
Funding
No specific funding was received for this manuscript. Diagnostic investigations were performed and funded by the treating institution (Royal Prince Alfred Hospital) in the course of the patient’s care.
Author information
Authors and Affiliations
Contributions
All co-authors have reviewed the manuscript and have contributed in a substantive and intellectual manner to the work described. The authors would like to acknowledge Dr Stephanie Anderson (Department of Haematology, Royal Prince Alfred Hospital) for providing images of the bone marrow aspirate.
Corresponding author
Ethics declarations
Conflict of interest
No author has any conflict of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Grey, A., Cheong, P.L., Lee, F.J. et al. A Case of VEXAS Syndrome Complicated by Hemophagocytic Lymphohistiocytosis. J Clin Immunol 41, 1648–1651 (2021). https://doi.org/10.1007/s10875-021-01070-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-021-01070-y